Dynamic Monitoring of ctDNA and HPV DNA in Plasma for the Early Prediction of Recurrence After Cervical Cancer Surgery

This study is monitoring blood samples from cervical cancer patients to detect early signs that cancer may be coming back after treatment. It looks for tiny fragments of tumor DNA (ctDNA) and HPV virus DNA circulating in the blood — like a liquid biopsy that could catch recurrence sooner than imaging. **You may be eligible if...** - You are 18 or older - You have newly diagnosed HPV-positive cervical cancer (stages I–IV) - You have not yet had surgery, radiation, or chemotherapy - You are eligible for surgery and/or chemoradiotherapy - Your expected survival is more than 3 months - You can provide blood samples at multiple time points **You may NOT be eligible if...** - You are already in another clinical trial - You are pregnant or breastfeeding - You have severe mental illness - You are unable to follow the study protocol Talk to your doctor to see if this trial is right for you.